Caspase-1, a cysteine protease, is critical for the production of mature IL-1b and IL-18, two pro-inflammatory cytokines that play an important role in host defense, sepsis, and the pathogenesis of several inflammatory diseases. In addition, dysregulated IL-1b production is a causative factor in the development of autoinflammatory disorders including familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal-onset multiple-system inflammatory disease. These inherited autoinflammatory syndromes are caused by missense mutations in NLRP3, a member of the NOD-like receptor (NLR) family. NLR family members including NOD1, NOD2, NLRC4 and NLRP3 are intracellular proteins that are involved in the recognition of microbial components and activation of inflammatory pathways against invading pathogens. Recent work from several laboratories including our own indicate that NLRP3 is critical for the activation of caspase-1 through its interaction with the adaptor molecule ASC and the formation of the inflammasome, a molecular platform that drives caspase-1 activation. We have obtained evidence that NLRP3 plays an important role in the activation of caspase-1 and IL-1b secretion in response to Toll-like receptor (TLR) ligands as well as infection with Staphylococcus aureus and Streptococcus pyogenes, two significant human pathogens. In addition, NLRP3 is critical for the activation of caspase-1 in response to particulate matter including silica and urate crystals. However, the molecular mechanism by which microbial and endogenous stimuli trigger caspase-1 activation via NLRP3 remains poorly understood. Our preliminary results revealed that TLR ligands and certain cytokines including TNF-a, IL-1a and IL-1b promote NLRP3-dependent caspase- 1 activation, at least in part, by the induction of NLRP3 via NF-kB. Unlike TLR agonists, we found that S. aureus and S. pyogenes activate the NLRP3 inflammasome via pore-forming toxins but independently of MyD88/TRIF and the purinergic P2X7 receptor. The goal of this proposal is to provide a better understanding of the mechanisms governing the activation and function of the NLRP3 inflammasome in response to ATP and bacterial toxins with a focus on ATP and S. aureus as model systems. Biochemical, genetic, and cellular approaches will be employed to study the function and activation of NLRP3. Given the important role of IL-1b in immunity and inflammatory disease, understanding of the mechanism involved in caspase-1 activation and IL-1b production via NLRP3 is expected to have a significant impact in the medical field

Public Health Relevance

The NLRP3 inflammasome is critical for host defense and contributes to inflammation in response to microbial stimuli and endogenous danger signals. Furthermore, NLRP3 is dysregulated by germline mutations in autoinflammatory syndromes and participates in the pathogenesis of several inflammatory disorders including gout, Crohn's disease, and diabetes. The main goal of this proposal is to understand the formation, regulation and activation of the NLRP3 inflammasome in response to endogenous signals and infectious agents. These studies may lead to better understanding of mechanisms that control host defense against human pathogens and the pathogenesis of inflammatory disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI063331-09
Application #
8581313
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Davidson, Wendy F
Project Start
2004-12-01
Project End
2015-11-30
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
9
Fiscal Year
2014
Total Cost
$332,910
Indirect Cost
$107,910
Name
University of Michigan Ann Arbor
Department
Pathology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Suzuki, Shiho; Mimuro, Hitomi; Kim, Minsoo et al. (2014) Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages. Proc Natl Acad Sci U S A 111:E4254-63
Franchi, Luigi; Eigenbrod, Tatjana; Muñoz-Planillo, Raúl et al. (2014) Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux. J Immunol 193:4214-22
Suzuki, Shiho; Franchi, Luigi; He, Yuan et al. (2014) Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkc?. PLoS Pathog 10:e1003926
He, Yuan; Varadarajan, Saranyaraajan; Munoz-Planillo, Raul et al. (2014) 3,4-methylenedioxy-*-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J Biol Chem 289:1142-50
He, Yuan; Franchi, Luigi; Nunez, Gabriel (2013) TLR agonists stimulate Nlrp3-dependent IL-1* production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol 190:334-9
Kim, Dong-Jae; Park, Jong-Hwan; Franchi, Luigi et al. (2013) The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1* production in Helicobacter pylori infected dendritic cells. Eur J Immunol 43:2650-8
Munoz-Planillo, Raul; Kuffa, Peter; Martinez-Colon, Giovanny et al. (2013) Kýýý efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142-53
Kamada, Nobuhiko; Nunez, Gabriel (2013) Role of the gut microbiota in the development and function of lymphoid cells. J Immunol 190:1389-95
He, Yuan; Franchi, Luigi; Nunez, Gabriel (2013) The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur J Immunol 43:1147-52
Tarallo, Valeria; Hirano, Yoshio; Gelfand, Bradley D et al. (2012) DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149:847-59

Showing the most recent 10 out of 33 publications